ZENO - Zenosense, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Zenosense, Inc.

Avenida Cortes Valencianas 58
Planta 5
Valencia 46015
34 960 45 42 02

IndustryDiagnostics & Research
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Carlos Jose GilCEO, Pres, Chief Accounting & Financial Officer, Treasurer, Sec. and Sole Director62.7kN/A1971
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Zenosense, Inc., through its joint venture, MIDS Medical Ltd., operates as a healthcare technology company. It develops MIDS Cardiac, a hand-held point of care cardiac diagnostic device targeting cardiac markers for the diagnosis of heart attack and cardiac related illnesses. The company was formerly known as Braeden Valley Mines, Inc. and changed its name to Zenosense, Inc. in November 2013. Zenosense, Inc. was founded in 2008 and is headquartered in Valencia, Spain.

Corporate Governance

Zenosense, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.